Stem cells show promise for deadly transplant complication
NCT ID NCT00284986
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 30 times
Summary
This study tested a stem cell treatment called Prochymal in 11 people with severe graft-versus-host disease (GVHD), a life-threatening complication after a bone marrow transplant. The treatment was given to patients whose GVHD did not improve with standard therapies. The goal was to see if it could safely control the disease and improve symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT VERSUS HOST DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University
Durham, North Carolina, 27708, United States
Conditions
Explore the condition pages connected to this study.